Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO
· Real-Time Price · USD
1.98
-0.06 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
2.02
2.28%
After-hours: Aug 15, 2025, 07:41 PM EDT
Aptevo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.02M | -23.7M | -24.13M | -24.01M | -25.25M | -27.31M | -17.7M | -16.15M | -17.46M | 18.5M | 8.03M | 6.4M | 7.04M | -28.9M | -28.46M | -29.24M | -29.03M | -27.9M |
Depreciation & Amortization | 265K | 307K | 352K | 397K | 436K | 495K | 567K | 612K | 711K | 837K | 901K | 1M | 1.07M | 1.1M | 1.14M | 1.23M | 1.23M | 1.24M |
Stock-Based Compensation | 94K | 530K | 1.07M | 1.5M | 1.8M | 2M | 2.19M | 2.19M | 2.1M | 2.12M | 1.8M | 1.62M | 1.58M | 1.67M | 1.64M | 1.66M | 1.69M | 1.42M |
Other Working Capital | -167K | 352K | 230K | -213K | -93K | 1.08M | 1.7M | -912K | -1.17M | -515K | -576K | 2.17M | 1.49M | -589K | 32.07M | 64.88M | 89.46M | 91.02M |
Other Non-Cash Items | -2.44M | -1.11M | 1.56M | 2.06M | 4.46M | 2.78M | 933K | 463K | -343K | -35.57M | -33.9M | -31.66M | -29.6M | 8.03M | 6.64M | 4.19M | 2.63M | 580K |
Deferred Income Tax | n/a | n/a | n/a | -201K | -979K | -630K | -630K | -429K | 349K | n/a | n/a | n/a | -1K | -1K | 4K | 4K | 5K | 5K |
Change in Working Capital | 1.46M | 1.6M | 554K | 176K | -1.58M | 1.58M | 2.91M | 896K | 1.58M | 2.78M | 2.14M | 3.68M | 2.6M | -1.19M | -2.65M | -1.77M | -2.58M | -976K |
Operating Cash Flow | -24.65M | -23.71M | -23.79M | -23.28M | -24.3M | -22.95M | -11.73M | -12.42M | -13.07M | -11.34M | -21.02M | -18.96M | -17.31M | -19.29M | -21.68M | -23.92M | -26.07M | -25.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | -29K | -54K | -54K | -147K | -156K | -522K | -713K | -683K | -670K | -279K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.12M | -28.12M | -28.12M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.12M | 56.24M | 56.24M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | -29K | -54K | -54K | -147K | -156K | -522K | -713K | -683K | 27.45M | 27.84M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -3.47M | -3.97M | -4.47M | -4.97M | -12.27M | -11.77M | -11.27M | -10.77M | -10.55M | -10.55M | -10.55M | -10.55M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | 10.23M | 10.23M | 10.23M | 10.23M | -11K | -11K | -11K |
Dividend Paid | n/a | n/a | n/a | -8K | -8K | -8K | -8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.56M | 5.56M | 5.56M | -6K | 3.14M | 3.14M | 3.13M | 9.63M | 6.49M | 3.38M | 9.21M | -359K | -3.47M | 7.96M | 36.62M | 60.95M | 88.79M | 80.47M |
Financial Cash Flow | 25.99M | 15.6M | 15.6M | 11.92M | 11.36M | 7.87M | 6M | 8.95M | 4.11M | 447K | -2.62M | -11.69M | -14.21M | -2.72M | 26.16M | 50.48M | 78.24M | 69.92M |
Net Cash Flow | 1.34M | -8.11M | -8.19M | -11.36M | -12.94M | -15.08M | -5.73M | -3.47M | -8.97M | -10.92M | -23.67M | -30.8M | -31.68M | -22.53M | 3.77M | 25.88M | 51.5M | 43.99M |
Free Cash Flow | -24.65M | -23.71M | -23.79M | -23.28M | -24.3M | -22.95M | -11.73M | -12.44M | -13.1M | -11.39M | -21.08M | -19.11M | -17.46M | -19.81M | -22.39M | -24.61M | -26.74M | -25.93M |